- US-listed companies
- ACURA PHARMACEUTICALS, INC
- Balance sheet
ACURA PHARMACEUTICALS, INCACUR
Market cap
P/E ratio
| 2011/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | |
| Cash and cash equivalents | 36 | 12 | 1 | 2 | 3 | 2 | 0 | 1 | 0 | 0 |
| Total cash & short-term investments | 36 | 12 | 1 | 2 | 3 | 2 | 0 | 1 | 0 | 0 |
| Inventories | - | - | 0 | 0 | 0 | - | - | - | - | - |
| Total current assets | 36 | 27 | 13 | 14 | 6 | 3 | 0 | 1 | 1 | 0 |
| Property, plant and equipment, net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Total non-current assets | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 0 |
| Total assets | 37 | 29 | 16 | 17 | 8 | 5 | 2 | 3 | 2 | 1 |
| Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Long-term debt, current | - | - | 2 | 2 | 2 | 3 | - | - | 6 | - |
| Total current liabilities | 1 | 1 | 3 | 3 | 3 | 5 | 1 | 1 | 8 | 1 |
| Long-term debt, non-current | - | 10 | 8 | 5 | 3 | - | - | 6 | - | - |
| Total non-current liabilities | - | 10 | 8 | 6 | 4 | - | 4 | 6 | 0 | 0 |
| Total liabilities | - | 11 | 11 | 9 | 7 | 5 | 6 | 7 | 8 | 1 |
| Common stock and paid-in capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Retained earnings | -326 | -349 | -362 | -367 | -375 | -380 | -384 | -388 | -389 | -390 |
| Stockholders' equity | 37 | 18 | 5 | 8 | 1 | -0 | -4 | -5 | -6 | 0 |
| Total debt | - | 10 | 10 | 8 | 5 | 3 | 4 | 6 | 6 | - |
| Net debt | - | -3 | 9 | 5 | 3 | 0 | 4 | 5 | 6 | - |
| D/E ratio (%) | - | 53.6 | 189.2 | 98.1 | 452.7 | -9,977.8 | -116.8 | -126.6 | -101.9 | - |